A study published in JAMA reports on data showing that Combination ICS-SABA and ICS-Formoterol asthma treatments are more ...
News Medical on MSN5d
New study confirms: Anti-inflammatory inhalers reduce severe asthma complicationsThis study highlights the benefits of anti-inflammatory inhalers in asthma management, showing reduced complications and ...
Adult patients (aged ≥18 years) with asthma who were receiving either salbutamol pMDI (Ventolin®, Allen & Hanburys Ltd) or terbutaline Turbuhaler® (Bricanyl®, Astra Pharmaceuticals Ltd ...
Early fall is when asthma flare-ups peak in the US ... GSK’s metered-dose Ventolin inhaler, prescribed to around 35 million people globally, accounts for 49% of the company’s entire carbon ...
Take the market for albuterol inhalers, filled with fast-acting drugs meant to stop an asthma attack in its tracks. Before the propellant switch, annual sales for the three brand-name inhalers had ...
The inhaler cleared the FDA’s desk in January 2023 as the first and only rescue medication for as-needed use to curb the risk of asthma exacerbations in adults. Unlike traditional albuterol ...
UK-based pharmaceutical company AstraZeneca has reported that its Phase IIIb BATURA trial of Airsupra (albuterol/budesonide) in patients with intermittent or mild persistent asthma met its primary ...
AstraZeneca (AZ) and Avillion have shared positive results from a phase 3b trial of their inhaled anti-inflammatory rescue medication in asthma patients aged 12 years and older. Airsupra ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback